Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- Check4 days agoChange DetectedThe history now lists Revision: v3.5.5, replacing the previous v3.5.4. This marks a new revision of the page's documentation within ClinicalTrials.gov.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe history updates to include a new site revision, v3.5.4, while the previous revision, v3.5.3, is removed from the record. This reflects a version bump in the site's release notes.SummaryDifference0.1%

- Check40 days agoChange DetectedA new page revision label, v3.5.3, was added and the previous v3.5.2 label was removed. This reflects an update to the page's version history metadata rather than changes to the study content.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check83 days agoChange DetectedThe record history shows the addition of revision 3.5.0 and the deletion of revision 3.4.3. These are metadata changes to the revision log and do not alter study details or eligibility.SummaryDifference0.1%

- Check90 days agoChange DetectedThe record history now lists an added entry for Revision: v3.4.3 and a deleted entry for Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.